Literature DB >> 17726745

Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients.

V Balachandar1, B Lakshman Kumar, K Sasikala, P Manikantan, R Sangeetha, S Mohana Devi.   

Abstract

The aim of the present investigation was to study the major chromosomal aberrations (CA) like deletion, translocation, inversion and mosaic in prostate cancer patients of Tamilnadu, Southern India. Totally 45 blood samples were collected from various hospitals in Tamilnadu, Southern India. Equal numbers of normal healthy subjects were chosen after signing a consent form. Volunteers provided blood samples (5 ml) to establish leukocyte cultures. Cytogenetic studies were performed by using Giemsa-banding technique and finally the results were ensured by spectral karyotyping (SKY) technique. In the present investigation, major CA like deletion, translocation, inversion and mosaic were identified in experimental subjects. Results showed frequent CA in chromosomes 1, 3, 5, 6, 7, 9, 13, 16, 18 and X. In comparison with experimental subjects, the control subjects exhibited very low levels of major CA (P<0.05). In the present study, the high frequency of centromeric rearrangements indicates a potential role for mitotic irregularities associated with the centromere in prostate cancer tumorigenesis. Identification of chromosome alterations may be helpful in understanding the molecular basis of the disease in better manner.

Entities:  

Mesh:

Year:  2007        PMID: 17726745      PMCID: PMC1963430          DOI: 10.1631/jzus.2007.B0638

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  45 in total

1.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

Authors:  M Gibbs; J L Stanford; R A McIndoe; G P Jarvik; S Kolb; E L Goode; L Chakrabarti; E F Schuster; V A Buckley; E L Miller; S Brandzel; S Li; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

2.  Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants.

Authors:  L S Cook; M Goldoft; S M Schwartz; N S Weiss
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

Review 3.  Epidemiology of prostate cancer.

Authors:  G P Haas; W A Sakr
Journal:  CA Cancer J Clin       Date:  1997 Sep-Oct       Impact factor: 508.702

4.  Identification of two distinct deleted regions on chromosome 13 in prostate cancer.

Authors:  C Li; C Larsson; A Futreal; J Lancaster; C Phelan; U Aspenblad; B Sundelin; Y Liu; P Ekman; G Auer; U S Bergerheim
Journal:  Oncogene       Date:  1998-01-29       Impact factor: 9.867

5.  Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma.

Authors:  R Dahiya; J McCarville; W Hu; C Lee; R M Chui; G Kaur; G Deng
Journal:  Int J Cancer       Date:  1997-03-28       Impact factor: 7.396

6.  Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer.

Authors:  T Ueda; A Komiya; M Emi; H Suzuki; T Shiraishi; R Yatani; M Masai; K Yasuda; H Ito
Journal:  Genes Chromosomes Cancer       Date:  1997-10       Impact factor: 5.006

7.  Cytogenetic Monitoring of Farmers exposed to pesticides in Colombia.

Authors:  L S Hoyos; S Carvajal; L Solano; J Rodriguez; L Orozco; Y López; W W Au
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

8.  Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

Authors:  J M Cunningham; A Shan; M J Wick; S K McDonnell; D J Schaid; D J Tester; J Qian; S Takahashi; R B Jenkins; D G Bostwick; S N Thibodeau
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

9.  Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).

Authors:  L Hagmar; S Bonassi; U Strömberg; A Brøgger; L E Knudsen; H Norppa; C Reuterwall
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

10.  Transcription map of Xq27: candidates for several X-linked diseases.

Authors:  I Zucchi; J Jones; M Affer; C Montagna; E Redolfi; L Susani; P Vezzoni; R Parvari; D Schlessinger; M P Whyte; S Mumm
Journal:  Genomics       Date:  1999-04-15       Impact factor: 5.736

View more
  3 in total

1.  KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state.

Authors:  David Frescas; Daniele Guardavaccaro; Shafi M Kuchay; Hiroyuki Kato; Andrey Poleshko; Venkatesha Basrur; Kojo S Elenitoba-Johnson; Richard A Katz; Michele Pagano
Journal:  Cell Cycle       Date:  2008-11-24       Impact factor: 4.534

2.  miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer.

Authors:  A Sacconi; F Biagioni; V Canu; F Mori; A Di Benedetto; L Lorenzon; C Ercolani; S Di Agostino; A M Cambria; S Germoni; G Grasso; R Blandino; V Panebianco; V Ziparo; O Federici; P Muti; S Strano; F Carboni; M Mottolese; M Diodoro; E Pescarmona; A Garofalo; G Blandino
Journal:  Cell Death Dis       Date:  2012-11-15       Impact factor: 8.469

Review 3.  The dark side of centromeres: types, causes and consequences of structural abnormalities implicating centromeric DNA.

Authors:  V Barra; D Fachinetti
Journal:  Nat Commun       Date:  2018-10-18       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.